Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Tiny needles with valproic acid can effectively regrow hair.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

New alopecia treatments aim for better results and fewer side effects.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Some alternative treatments for hair loss might work, but more research is needed.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Gene network oscillations inside hair stem cells are key for hair growth regulation and could help treat hair loss.